No difference in treatment efficacy was observed between intranasal mometasone furoate and saline for the management of sleep-disordered breathing (SDB) symptoms in children, with findings indicating ...
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older WHITEHOUSE STATION, N.J., Jun ...
Merck announced results from two Phase 3 studies investigating fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) for the management of asthma, for which a New Drug ...
November 29, 2010 (Phoenix, Arizona) — Once-daily mometasone furoate nasal spray relieves nighttime and early morning nasal congestion in patients with seasonal allergic rhinitis, according to a post ...
Woman in bed with inhalers. The combined use of mometasone furoate and formoterol in adults and adolescents with persistent asthma may not increase asthma-related adverse events and may reduce the ...
HONOLULU--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from two 26-week investigational Phase III clinical studies evaluating the ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA ® (mometasone furoate and formoterol fumarate dihydrate) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results